(I-BusinessNews.Com, February 27, 2021 ) According to market research report the global Coagulation Analyzers Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392
Coagulation analyzers and consumables are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. They are primarily used in wound, injury, and pre- and post-operative management.
The prominent players operating in the coagulation analyzers market include Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Abbott, Inc. (US), Sysmex Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), Nihon Kohden Corporation (Japan), Thermo Fisher Scientific (US), and Horiba Medical (Japan). Players in this market focused on partnerships, collaborations, agreements, acquisitions, mergers, expansions, and product launches & approvals to expand their market presence between January 2017 and February 2020.
Thermo Fisher Scientific (US)
Thermo Fisher held the second position in the global coagulation analyzers market. The company is a leading provider of life science diagnostic tools. Thermo Fisher has a significant global footprint owing to its strong sales and distribution network. The strong position of the company in this market can be attributed to its strong brand value. The company also has a strong distribution network for sales and services, making it a prominent player in the coagulation analyzers market.
Roche Diagnostics (Switzerland)
Roche Diagnostics held the third position in the global coagulation analyzers market. The company focuses on introducing innovative and technologically advanced products in the market. For instance, in June 2017, Roche launched the cobas t 711 coagulation analyzer. The company has a strong portfolio of coagulation analyzers, as well as reagents and assays.
Siemens Healthineers (Germany)
Siemens Healthineers focuses on the introduction of innovative products to gain a competitive advantage in the market. For instance, in August 2016, Siemens launched the Sysmex CS-2500 System, a new mid-volume coagulation analyzer. The company also pursues the inorganic growth strategy of agreements in order to increase its share in the market. In April 2016, Siemens and Sysmex (Japan) extended their long-standing global agreement on hemostasis testing. This agreement allows laboratory customers around the world to continue to benefit from the largest portfolio of hemostasis systems and reagents.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392
North America is the largest regional market for coagulation analyzers
North America (comprising the US and Canada) accounted for the largest share of the global Coagulation Analyzers Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
